Houston Methodist

11th Annual Nantz National Alzheimer Center Symposium Plasma Biomarkers and New Treatments for Alzheimer’s Disease and Related Disorders

The Nantz National Alzheimer Center symposium will examine the striking advances made in the identification of plasma biomarkers for Alzheimer’s disease and related disorders. Plasma biomarkers will allow for the identification of people at risk and, likely, for measuring the speed of disease progression. Thus, they will be critical in clinical trials and for the application of new therapies. 

Friday, February 18 at 8:30am to 5:00pm

Virtual Houston

Event Type

Conference

Attendance Options

Livestream Video

Continuing Education Credit

CME, CNE, Other CE

Category

Clinical

Website

https://www.cvent.com/d/r8qz59

Department & Center
Neurological Institute
Subscribe
Google Calendar iCal Outlook

You're not going yet!

This event requires registration.